Vice President – General Manager, EU North

Job Description

Establish the EU North operating entity from its start, including recruiting the core leadership team, setting up legal and infrastructure, and ensuring governance in coordination with International HQ. Lead the planning and execution of launches for infigratinib, encaleret, and subsequent pipeline assets across Nordic markets, carefully sequencing and pacing investments by country. Spearhead BridgeBio's engagement in market access, craft evidence strategies, and ensure organizational readiness in the UK and Ireland. Provide strategic direction on when and how to transition to active launch for each asset. Take full ownership of the cluster's P&L, encompassing forecasting, investment prioritization, risk management, and performance delivery across launch, pre-launch, and in-line periods. Develop and implement reimbursement and pricing strategies tailored to each national authority in the cluster. This includes early scientific advice, evidence planning, managed-entry agreements, and risk-sharing frameworks. Build and maintain strong relationships with leading cardiologists, endocrinologists, and skeletal dysplasia specialists across the cluster. Ensure BridgeBio is seen as the preferred scientific and clinical partner in ATTR-CM, achondroplasia, and ADH1/chronic hypoparathyroidism. The General Manager will personally engage in this effort as a senior, credible, and mission-driven figure. Establish BridgeBio as a trusted, long-term partner to patient organizations in the ATTR amyloidosis, achondroplasia, hypoparathyroidism, and ADH1 communities. Acknowledge that in rare disease, the patient's voice is key to access, policy influence, and our operating credibility, and lead accordingly. Collaborate closely with Medical Affairs, Regulatory, Market Access, Finance, Legal, Compliance, and Commercial Operations at International HQ to deliver a cohesive launch and pre-launch strategy across all three regions. Represent BridgeBio externally with integrity, engaging with national industry associations, compliance frameworks, and broader EU and national policy platforms. Anticipate macroeconomic, political, regulatory, and competitive trends in the region and translate these insights into actionable strategies for the business. Reinforce BridgeBio's core values in every hiring decision, partnership, and interaction.

Qualifications

1. At least ten years in senior commercial leadership roles with P&L responsibility, including at least one direct launch cycle within the EU North cluster (Nordics and/or UK) 2. Commercial launch experience in rare disease, orphan drugs, or specialty medicines, with demonstrated ability to navigate complex HTA and reimbursement environments 3. Deep working knowledge of market access across multiple countries in the cluster – engagement with authorities such as TLV, Nye Metoder, Medicinrådet, Fimea, NICE, SMC, and the NCPE – and experience with managed-access and risk-sharing agreements 4. Demonstrated personal track record of building and sustaining senior KOL and patient advocacy relationships in a rare disease or specialty context 5. Demonstrated ability to build and lead and leading high-performance teams in a start-up, early-affiliate, or greenfield environment 6. Experience operating across functions and geographies within a matrixed international organization 7. Prior launch or commercialization experience in cardiology, endocrinology, or skeletal dysplasia indications 8. Demonstrated capacity to carry both a launch market and a pre-launch market concurrently, with sound judgement on where to invest ahead of revenue 9. Background combining a larger company launch pedigree with a demonstrated capacity to operate in a lean, entrepreneurial setting 10. Fluency in English required. Fluency in one or more additional cluster languages is an asset but not a requirement.

Benefits

- Market leading compensation - Hybrid work model - we value your flexibility in how you work, but encourage time in the office to strengthen our culture, collaboration, and sense of community - We provide career development through regular feedback, continuous education and professional development programs - We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities